Federal Judge Allows Collective Lawsuit Against Juul Marketing

Jun.30.2022
Federal Judge Allows Collective Lawsuit Against Juul Marketing
A US federal judge allows collective lawsuits against Juul, accusing the company of misleading marketing and demanding compensation for its purchasers.

A federal judge has permitted both adult and underage individuals who have purchased Juul e-cigarettes to file a collective lawsuit, demanding compensation from the company for deceptive marketing practices.

 

On Tuesday, U.S. District Judge William Orrick certified four groups, consisting of adults and minors both nationwide and in California, but rejected arguments made by Juul and its largest shareholder, tobacco giant Altria Group Inc., stating that the potential members of the collective were too diverse to bring a lawsuit for their claims together.

 

These class-action lawsuits do not accuse the product of causing bodily harm, but rather demand a refund of the money spent on purchasing Juul products.

 

The above is part of the multi-district litigation being handled by Orrick, which includes personal injury claims and lawsuits brought by local governments and school districts alleging that Juul fueled an epidemic of youth addiction.

 

Lawyers for plaintiffs Juul and Altria did not immediately respond to requests for comment.

 

The economic loss claims allege that Juul downplayed the addictive nature of its products and, had it not been for deceptive marketing, consumers would not have purchased these products or would have spent less money on them.

 

Juul argues that they should not be classified as a class-action lawsuit because different consumers were exposed to different advertisements, and some individuals became addicted while others did not.

 

However, Orrick believes that these differences are "largely immaterial under the legal theory being asserted.

 

Under pressure from regulators, Juul removed popular flavors such as mango and cucumber from retail stores in 2018 and closed its social media channels on Instagram and Facebook.

 

Earlier this month, the US Food and Drug Administration (FDA) ordered the removal of all Juul e-cigarettes from the market, but this decision was temporarily halted by the federal appeals court.

 

Juul has agreed to pay over $87 million to settle charges related to its marketing of products to minors with four states.

 

Source: Reuters

 

This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

UK Court Sentences Shrewsbury Retailer for Illegal Vape and Counterfeit Tobacco Sales
UK Court Sentences Shrewsbury Retailer for Illegal Vape and Counterfeit Tobacco Sales
A UK local authority has secured convictions against a Shrewsbury retailer and its former director for selling illegal disposable vapes, counterfeit tobacco and a nicotine vape to a minor, highlighting continued enforcement against non-compliant nicotine products.
Feb.05 by 2FIRSTS.ai
Editorial says West Virginia’s HB 5437 “Vape Safety Act” goes too far, targeting residency and citizenship provisions
Editorial says West Virginia’s HB 5437 “Vape Safety Act” goes too far, targeting residency and citizenship provisions
A News and Sentinel editorial argues that West Virginia’s HB 5437, the “Vape Safety Act,” goes beyond reasonable regulation by adding provisions barring any part of a vape or smoke shop from being used as a residence and requiring owners to be U.S. citizens.
Feb.27 by 2FIRSTS.ai
Cyprus customs seizes 269 packs containing cannabis and THC; Pharmacy Department flags unauthorized CBD products
Cyprus customs seizes 269 packs containing cannabis and THC; Pharmacy Department flags unauthorized CBD products
The report says an international operation across EU countries aimed at detecting illicit substances in e-cigarettes also took place in South Cyprus, where multiple e-liquid items and products containing cannabis and THC were seized. It states the operation, titled “eVAPER8,” was conducted by the International Narcotics Control Board (INCB) in November and December to identify e-cigarette liquids that may contain synthetic drugs.
Feb.09 by 2FIRSTS.ai
Special Report | Belarus Rejects Vape Ban, Opts for Tighter Market Controls
Special Report | Belarus Rejects Vape Ban, Opts for Tighter Market Controls
After weeks of debate over a potential blanket prohibition, Belarus has decided against banning electronic cigarettes, choosing instead to tighten control over wholesale, imports and licensing. President Alexander Lukashenko warned that an outright ban could drive the market underground and undermine state revenues, as officials move to curb widespread illicit trade while keeping retail sales largely intact.
Mar.04
Thai Vape User Numbers Rose More Than 11-Fold in Three Years, Group Says Ban Should Be Reassessed
Thai Vape User Numbers Rose More Than 11-Fold in Three Years, Group Says Ban Should Be Reassessed
A network of e-cigarette users in Thailand has urged the new government to review the country’s vape ban, saying official data show that use has risen sharply despite more than a decade of prohibition.
Mar.27 by 2FIRSTS.ai
PMTA Roundtable Opens with Industry Questioning Product Characterization Standards, FDA Defends Regulatory Boundaries
PMTA Roundtable Opens with Industry Questioning Product Characterization Standards, FDA Defends Regulatory Boundaries
At the opening of FDA’s PMTA roundtable, small ENDS manufacturers warned that unclear product characterization standards are limiting their ability to invest and raise capital. FDA officials acknowledged industry concerns but said regulatory flexibility is constrained by statutory and procedural boundaries.
Feb.11